Daniel Guay

USPTO Granted Patents = 35 (Patent Applications = 5)

CIPO Patents = 3 (Patent Applications = 2)

EPO Patents = 5 (Patent Applications = 3)

Average Co-Inventor Count = 5.4

ph-index = 15

Forward Citations = 1,271(Granted Patents)

Location History:

Notre Dame de Ile Perrot, CA (1993 - 1996)
Iie Perrot, CA (1996)
Ille Perrot, CA (1998)
Montreal, CA (1996 - 1999)
Quebec, CA (1996 - 1999)
Kirkland, CA (1999 - 2001)
L'ille Perrot, CA (2001)
Notre-Dame de I'Ile Perrot, CA (2002)
Notre Dame De L'lle Perrot, CA (1995 - 2004)
Ile Perrot, CA (1997 - 2004)
Notre-Dame de I'lle Perrot, CA (2005 - 2006)
Notre Dam de I'lle Perrot, CA (2006)
Vaudreuil-Dorion, CA (2009)
St-Lambert, CA (2004 - 2015)
Lachine, CA (2013 - 2017)
Saint-Lambert, CA (2013 - 2019)

Company Filing History:

16 out of 212

Merck Frosst Canada, Inc.

patents

9 out of 76

Merck Frosst Canada & Co.

patents

5 out of 2,405

Merck Sharp + Dohme Corp.

Institut National De La Recherche Scientifique

National Research Council of Canada

patents

where one patent can have more than one assignee

Years Active: 1993-2019

Loading Chart...

35 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 10189084 - Method and system for fabrication of hydrogen-permeable membranes (2019-01-29),

2. 9745295 - Thiazole-substituted aminoheteroaryls as spleen tyrosine kinase inhibitors (2017-08-29),

3. 9586931 - Triazolyl derivatives as Syk inhibitors (2017-03-07),

4. 9353066 - Substituted phenyl-Spleen Tyrosine Kinase (Syk) inhibitors (2016-05-31),

5. 9242984 - Pyrazolyl derivatives as Syk inhibitors (2016-01-26),

6. 9108843 - Method and system for preparation of highly porous and preferentially-oriented {100} platinum nanowires and thin films (2015-08-18),

7. 8551984 - Aminopyrimidines as SYK inhibitors (2013-10-08),

8. 8470410 - Method and system for producing electrocatalytic coatings and electrodes (2013-06-25),

9. 7622501 - Nitric oxide releasing prodrugs of diaryl-2-(5H)-furanones as cyclooxygenase-2 inhibitors (2009-11-24),

10. 7144913 - Dihydropyrrolo[1,2-a]indole and tetrahydropyrido[1,2-a]-indole derivatives as prostaglandin d2 receptor antagonists (2006-12-05),

11. 7019022 - Substituted tetrahydrocarbazole and cyclopentanoindole derivatives (2006-03-28),

12. 6841564 - Tri-aryl-substituted-ethane PDE4 inhibitors (2005-01-11),

13. 6743802 - Alkyne-aryl phosphodiesterase-4 inhibitors (2004-06-01),

14. 6680042 - Method of rapidly carrying out a hydrogenation of a hydrogen storage material (2004-01-20),

15. 6677351 - 1-biaryl-1,8-naphthyridin-4-one phosphodiesterase-4 inhibitors (2004-01-13),

Title: The Inventor Profile of Daniel Guay

Introduction: Daniel Guay is a renowned inventor hailing from Lachine, Canada. With a passion for innovation and problem-solving, he has made significant contributions to the field of technology through his inventive spirit.

Latest Patents: Daniel Guay holds several patents in various technological domains, showcasing his versatility and creativity in inventing novel solutions to complex problems.

Career Highlights: Throughout his career, Daniel Guay has been recognized for his groundbreaking inventions that have had a positive impact on industries such as robotics, artificial intelligence, and renewable energy. His innovative approach to problem-solving has led to the development of cutting-edge technologies that have revolutionized the way we live and work.

Collaborations: Daniel Guay has collaborated with leading tech companies, research institutions, and universities to further his research and bring his inventions to life. His collaborative efforts have resulted in the successful implementation of his innovative ideas in real-world applications.

Conclusion: In conclusion, Daniel Guay is a visionary inventor whose passion for innovation and dedication to pushing the boundaries of technology have established him as a prominent figure in the world of inventions. His contributions continue to inspire the next generation of inventors to think creatively and strive for excellence in their pursuits.

This text is generated by artificial intelligence and may not be accurate.